By Rich Haridy May 17, 2021 An asthma vaccine was found to be effective in preclinical mouse models and researchers are now looking to move to human safety trialsalliesinteract/Depositphotos A new article in the journal Nature Communications is reporting successful results from preclinical tests for a unique asthma vaccine. The results indicate the vaccine generates antibodies against...
INSTITUT PASTEUR Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic asthma, reducing the severity of its symptoms and thus significantly improving patient quality of life. Their research in animals has been published in the...
